试验面试,以探索糖原储存疾病型 Ia 患者经验 基因治疗后的经验
Diane M Turner-Bowker1, Jessica Butler2, Shayna Egan3
1Ultragenyx Pharmaceutical, Inc., Novato, California, USA.
Journal of health economics and outcomes research
|February 16, 2026
概括
基因疗法DTX401显著改善了Glycogen存储疾病类型Ia (GSDIa) 患者的症状,并减少了患者的日常负担. 大多数参与者报告说,他们的健康和生活质量有所改善,尽管面临小挑战,但他们的满意度很高.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 基因治疗是一种基因疗法.
- 患者报告的结果
背景情况:
- 糖原储存疾病Ia型 (GSDIa) 是一种罕见的遗传疾病,影响葡萄糖代谢.
- 患者依赖于经常摄入碳水化合物,通常是未煮熟的玉米粉,导致严重的负担和并发症.
- DTX401是一种使用AAV8载体恢复葡萄糖生产的试验性基因疗法.
研究的目的:
- 为了评估患者的经验和报告的结果与DTX401基因治疗在成年人的GSDIa.
- 评估DTX401对症状,日常负担和生活质量的影响.
主要方法:
- 开放标签,阶段1/2试验 (NCT03517085) 涉及成年人与GSDIa.
- 在第24周,第52周和第104周进行的半结构化电话采访.
- 面试成绩单的定性分析.
主要成果:
- 86%的参与者报告了整体症状改善和减轻负担.
- 大多数患者体验到身体功能,饮食管理和整体健康状况的改善.
- 时间点的满意度仍然很高,有86%的人在第104周表示有点或非常满意.
结论:
- DTX401基因治疗导致玉米粉摄入量大幅减少,并改善了GSDIa患者的生活质量.
- 大多数参与者报告了积极的体验和高满意度,表明治疗解决了患者识别的关键负担.
- 建议对饮食变化进行密切监测和指导,以获得最佳的基因治疗患者结果.
相关概念视频
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Hypoglycemia and Glucagon
1.0K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.0K
Kidney Transplant I: Introduction
514
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
514
Cystic Fibrosis: Management
549
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
549
Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K


